MedPath

Lactulose Solution

Lactulose Solution USP, 10 g/15 mL Rising Pharmaceuticals, Inc.

Approved
Approval ID

e75c335b-f19e-42e2-a24f-d891a52d3d34

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 31, 2023

Manufacturers
FDA

Rising Pharmaceuticals, Inc.

DUNS: 041241766

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lactulose Solution USP, 10 g/15 mL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64980-592
Application NumberANDA076645
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lactulose Solution USP, 10 g/15 mL
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateMay 24, 2023
FDA Product Classification

INGREDIENTS (4)

D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
LACTULOSEActive
Quantity: 10 g in 15 mL
Code: 9U7D5QH5AE
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lactulose Solution - FDA Drug Approval Details